Results 211 to 220 of about 210,826 (348)
AIE‐active tetranuclear Ir(III) complex Ir‐4 as a sonosensitizer/sonocatalyst is formulated into a nanoplatform with an H2S donor. Ir‐4@S‐R NPs achieves combined endogenous NIR chemiluminescence imaging, sonodynamic therapy and release of H2S in situ by a bioorthogonal sonocatalytic reaction in vivo, achieving safe thrombolysis and anti‐inflammatory ...
Zihan Wu+11 more
wiley +1 more source
Thermally Actuated Soft Robotics
This review focuses on the recent development of thermally actuated soft robotics, highlighting the four major heating mechanisms, as well as structural designs, thermal management, material innovations, and emerging applications. A summary and outlook section present the current challenges of thermally actuated soft robots and the future directions to
Shuang Wu+2 more
wiley +1 more source
Ischaemic heart disease and cardiovascular mortality in the Philippines: Current status and strategic policy insights. [PDF]
Rogayan DV, Reusia DHR.
europepmc +1 more source
Dendrimers Improve Apolipoprotein Nanoparticle mRNA Delivery to Immune Cells
Apolipoprotein nanoparticle (aNP) platform technology efficiently delivers RNA to immune cells following systemic administration. Here, it is demonstrated that incorporating polyvalent ionizable cationic dendrimers in aNPs enables robust mRNA complexation and functional delivery.
Mirre M. Trines+24 more
wiley +1 more source
SGLT2 inhibitors and mortality in diabetic cancer patients: cardioprotective and anticancer effects. [PDF]
Keramida K, Ahmed A, Filippatos G.
europepmc +1 more source
Membrane proeteins as markers for normal and neoplastic endocrine cells [PDF]
Gratzl, Manfred+2 more
core
Understanding the bi‐directional crosstalk between cells and their surrounding extracellular matrix (ECM) is critical for tissue engineering. This study presents a chemoselective strategy for proteomic profiling of newly deposited ECM from resident cells.
Zihan Ling+9 more
wiley +1 more source
Cardiovascular Disease Mortality Risk among Long-term Survivors of Different Hodgkin Lymphoma Types. [PDF]
Lu Z+9 more
europepmc +1 more source